Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
J Pain Symptom Manage. 2021 Jun;61(6):1139-1146. doi: 10.1016/j.jpainsymman.2020.10.027. Epub 2020 Nov 1.
As the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) increases, decisions regarding withdrawal from VA-ECMO increase.
To evaluate the clinical characteristics of patients withdrawn from VA-ECMO and the role of palliative care consultation in the decision.
We retrospectively reviewed adult patients with cardiogenic shock requiring VA-ECMO at our institution, who were withdrawn from VA-ECMO between January 1, 2014 and May 31, 2019. The relationship between clinical characteristics and palliative care visits was assessed, and documented reasons for withdrawal were identified.
Of 460 patients who received VA-ECMO, 91 deceased patients (19.8%) were included. Forty-two patients (44.8%) had a palliative care consultation. The median duration on VA-ECMO was 4.0 days (interquartile range 8.8), and it was significantly longer for patients with palliative care consultation than those without (8.8 days vs. 2.0 days, P < 0.001). Among those with palliative care consultation, those with early consultation (within three days) had significantly shorter duration of VA-ECMO compared with those with late consultation (7.6 days vs. 13.5 days, t = 2.022, P = 0.008). Twenty-two (24.2%) had evidence of brain injury, which was significantly associated with patient age, number of comorbidities, duration of VA-ECMO, number of life-sustaining therapies, and number of palliative care visits (Wilks lambda 0.8925, DF 5,121, P = 0.016). Presence of brain injury was associated with fewer palliative care visits (t = 2.82, P = 0.006).
Shorter duration of VA-ECMO support and presence of brain injury were associated with fewer palliative care visits. Decisions around withdrawal of VA-ECMO support might be less complicated when patient's medical conditions deteriorate quickly or when neurological prognosis seems poor.
随着静脉-动脉体外膜肺氧合(VA-ECMO)的应用增加,关于停止 VA-ECMO 的决策也随之增加。
评估从 VA-ECMO 中撤出的患者的临床特征,以及姑息治疗咨询在该决策中的作用。
我们回顾性分析了 2014 年 1 月 1 日至 2019 年 5 月 31 日期间在我院接受 VA-ECMO 的成人心源性休克患者,这些患者从 VA-ECMO 中撤出。评估了临床特征与姑息治疗咨询之间的关系,并确定了撤出的原因。
在 460 名接受 VA-ECMO 的患者中,有 91 名死亡患者(19.8%)被纳入研究。42 名患者(44.8%)接受了姑息治疗咨询。VA-ECMO 的中位持续时间为 4.0 天(四分位距 8.8),接受姑息治疗咨询的患者明显长于未接受姑息治疗咨询的患者(8.8 天 vs. 2.0 天,P<0.001)。在接受姑息治疗咨询的患者中,早期咨询(3 天内)的患者 VA-ECMO 持续时间明显短于晚期咨询的患者(7.6 天 vs. 13.5 天,t=2.022,P=0.008)。22 名患者(24.2%)有脑损伤证据,脑损伤与患者年龄、合并症数量、VA-ECMO 持续时间、生命支持治疗数量和姑息治疗咨询数量显著相关(Wilks lambda 0.8925,DF 5,121,P=0.016)。脑损伤患者的姑息治疗咨询次数较少(t=2.82,P=0.006)。
VA-ECMO 支持时间较短和存在脑损伤与姑息治疗咨询次数较少相关。当患者的病情迅速恶化或神经预后较差时,VA-ECMO 支持的撤出决策可能会变得不那么复杂。